These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12243929)
1. International panel considers global patent system needs reassessment. Ashraf H Lancet; 2002 Sep; 360(9336):858. PubMed ID: 12243929 [No Abstract] [Full Text] [Related]
2. Intellectual property and access to ART: unwise choice of terminology. Stallman R PLoS Med; 2006 Nov; 3(11):e509; author reply e510. PubMed ID: 17132062 [No Abstract] [Full Text] [Related]
3. USA-Morocco deal may extend drug patents to 30 years. Ahmad K Lancet; 2003 Dec; 362(9399):1904. PubMed ID: 14672079 [No Abstract] [Full Text] [Related]
4. International patent law-boon or bane of biotech? Basu P Nat Biotechnol; 2005 Jan; 23(1):13-5. PubMed ID: 15637604 [No Abstract] [Full Text] [Related]
6. International intellectual property strategies for therapeutic antibodies. Storz U MAbs; 2011; 3(6):596-606. PubMed ID: 22123063 [TBL] [Abstract][Full Text] [Related]
7. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries. Spectar JM Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914 [No Abstract] [Full Text] [Related]
8. Patents & public health: international trade obligations and domestic policy development. Amani B Health Law Can; 2002 Feb; 22(3):76-84. PubMed ID: 11915591 [No Abstract] [Full Text] [Related]
9. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand. Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042 [TBL] [Abstract][Full Text] [Related]
11. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals. Correa CM Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300 [No Abstract] [Full Text] [Related]
12. US trade rules seek to balance health and patent protection. Wadman M; Cherry M Nature; 1999 Dec; 402(6762):567-8. PubMed ID: 10604448 [No Abstract] [Full Text] [Related]
13. Ending drug registration apartheid: taming data exclusivity and patent/registration linkage. Baker BK Am J Law Med; 2008; 34(2-3):303-44. PubMed ID: 18697696 [No Abstract] [Full Text] [Related]
14. How do intellectual property law and international trade agreements affect access to antiretroviral therapy? Westerhaus M; Castro A PLoS Med; 2006 Aug; 3(8):e332. PubMed ID: 16881728 [TBL] [Abstract][Full Text] [Related]
16. Analyzing the impact of the European unitary patent system on worldwide biotechnology. Belda I; Penas G; Marquina D; Santos A Trends Biotechnol; 2014 Aug; 32(8):393-5. PubMed ID: 25059513 [TBL] [Abstract][Full Text] [Related]
17. A general approach for determining when to patent, publish, or protect information as a trade secret. Daizadeh I; Miller D; Glowalla A; Leamer M; Nandi R; Numark CI Nat Biotechnol; 2002 Oct; 20(10):1053-4. PubMed ID: 12355117 [No Abstract] [Full Text] [Related]
18. TRIPS: whose interests are being served? Kamal M; Bailey M Lancet; 2003 Jul; 362(9380):260. PubMed ID: 12892952 [No Abstract] [Full Text] [Related]
19. Intellectual property protection for plant-related inventions in Europe. Fleck B; Baldock C Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379 [TBL] [Abstract][Full Text] [Related]
20. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health? Oliveira MA; Bermudez JA; Chaves GC; Velásquez G Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]